WEX Inc. WEX
Composite 57/100; the shares have moved about 45% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 37/100 — a moderate mark against it.
Valuation ranks 72/100 — a moderate point in its favour. Quality ranks 68/100 — a moderate point in its favour. Momentum ranks 67/100 — a moderate point in its favour.
Balance-sheet strength ranks 37/100 — a moderate mark against it. Growth ranks 39/100 — a slight mark against it.
What the company does WEX Inc. operates a commerce platform with three segments: Mobility (fleet/fuel payments), Corporate Payments (embedded payments, AP automation), and Benefits (healthcare SaaS). Its platform serves commercial fleets, fintech, insurance, and healthcare verticals with transaction processing, analytics, and spend management tools.
Key financials WEX reports strong profitability: ROE 30.2%, ROA 2.9%, ROCE 13.8%, net margin 12.6%, and gross margin 73.2%. Revenue grew 14.2% and EPS 57.1%, but leverage is high (Debt/Equity 3.98). Forward P/E is 8.86 vs trailing 17.76, with EV/EBITDA at 6.03 and FCF yield 21.0%.
Stock health Momentum is mixed: +20.52% over 3/6 months, +7.09% over 12 months, but -2.60% from its 52-week high. RSI(14) is 73.80, suggesting overbought conditions. Sideravia scores Valuation 74.8 (top quartile) but Quality 62.7 and Strength 39.3 (below average).
Price vs fair value WEX trades at a **discount** of 86.50% to our fair-value estimate of 347.61 and a **discount** of 2.09% to the 12-month target of 190.30. - Recent AI fraud tool launch cited as growth driver (Simply Wall St.) - Analysts highlight strong Q2 beats across peers, lifting sentiment (Zacks) - Forward PEG of 0.09 and EV/EBITDA 6.03 support valuation appeal - High leverage and low Altman Z (0.81) remain risks
Looking forward Forward earnings multiple of 8.86x implies potential rerating if execution on AI and embedded payments gains traction. Watch segment mix (Mobility vs Corporate Payments vs Benefits) and leverage reduction for upside catalysts.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.